Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 13.98
-0.427 %
$ 6.91 B
Market Cap
34.1
P/E
CASH FLOW STATEMENT
271 M
OPERATING CASH FLOW
-169 M
INVESTING CASH FLOW
-83 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Elanco Animal Health Incorporated
| Net Income | -1.23 B |
| Depreciation & Amortization | 694 M |
| Capital Expenditures | -154 M |
| Stock-Based Compensation | 46 M |
| Change in Working Capital | -300 M |
| Others | 1.14 B |
| Free Cash Flow | 117 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (1 231.0) | (78.0) | (472.0) | (560.1) | 67.9 | 86.5 | (310.7) | (47.9) | (210.8) |
| Depreciation & Amortization | 694.0 | 682.0 | 716.0 | 516.9 | 314.5 | 296.0 | 318.4 | 254.4 | 236.9 |
| Deferred Income Tax | (80.0) | (57.0) | (154.0) | (124.8) | 100 K | (60.7) | (13.4) | (5.9) | (76.2) |
| Stock Based Compensation | 46.0 | 59.0 | 66.0 | 47.0 | 49.4 | 26.0 | 25.0 | 20.4 | 13.4 |
| Other Operating Activities | 1 142.0 | 308.0 | 414.0 | (86.4) | 19.9 | 168.7 | 101.0 | 104.3 | 59.0 |
| Change in Working Capital | (300.0) | (462.0) | (87.0) | 165.7 | (227.7) | (29.2) | 53.5 | (169.4) | (15.7) |
| Cash From Operations | 271.0 | 452.0 | 483.0 | (41.0) | 224.1 | 487.3 | 173.8 | 155.9 | 6.6 |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (154.0) | (184.0) | (197.0) | (310.9) | (197.4) | (134.5) | (98.6) | (110.3) | (100.1) |
| Other Items | (15.0) | 5.0 | (333.0) | (4 468.3) | (37.4) | 7.5 | (866.0) | (71.8) | (4 895.3) |
| Cash From Investing Activities | (169.0) | (179.0) | (530.0) | (4 779.2) | (234.8) | (127.0) | (964.6) | (182.1) | (4 995.4) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (77.0) | (517.0) | 177.0 | 3 852.0 | (121.0) | 2 492.5 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (6.0) | (32.0) | 33.0 | (118.1) | (183.8) | (2 527.7) | 847.5 | (149.6) | 5 353.2 |
| Cash From Financing Activities | (83.0) | (549.0) | 210.0 | 4 953.9 | (304.8) | (35.2) | 847.5 | (149.6) | 5 353.2 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | 7.0 | (293.0) | 132.0 | 160.3 | (332.4) | 354.1 | 64.6 | (201.8) | 344.6 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | 117.0 | 268.0 | 286.0 | (351.9) | 26.7 | 352.8 | 75.2 | 45.6 | (93.5) |